Skip to main content

Market Overview

UPDATE: Bank of America Merrill Lynch Downgrades Nu Skin Enterprises

Share:

In a report published Friday, BofA Merrill Lynch analyst Olivia Tong downgraded Nu Skin Enterprises (NYSE: NUS) from Buy to Neutral, with a $94.00 price objective.

According to the report, earlier this week, an article in China's People's Daily suggested that NUS was engaging in improper selling practices amongst other things. The following day, China's State Administration for Industry and Commerce (SAIC) said that it would look into the People's Daily's claims. NUS announced intraday yesterday that it is launching its own review of its China branch.

“While the likely duration of the investigation into NUS is unclear, our China Strategy team noted in a July 2013 report ‘What all these investigations of foreign firms are about' that of the investigations into foreign companies it analyzed, 53% were completed within six months, but 36% are either still ongoing or have unknown end dates, suggesting to us that if resolution to Nu Skin's government inquiry is positive (i.e., no action), it may not be immediately apparent to the market,” the report noted.

The report further asserted that their scenario analysis suggest that even assuming only a 10 percent probability that NUS is ultimately out of China our implied current fair value is $85.00, with a 12 month upside to $94.00 based on 14x P/E.

NUS closed Thursday at $84.80 with shares trading down at 26.41 percent.

Latest Ratings for NUS

DateFirmActionFromTo
Feb 2021DA DavidsonDowngradesBuyNeutral
Feb 2021JefferiesMaintainsBuy
Oct 2020DA DavidsonMaintainsBuy

View More Analyst Ratings for NUS
View the Latest Analyst Ratings

 

Related Articles (NUS)

View Comments and Join the Discussion!

Posted-In: Bank of America Merrill Lynch Olivia TongAnalyst Color Downgrades Analyst Ratings

Latest Ratings

StockFirmActionPT
CGNXMorgan StanleyMaintains72.0
NETMorgan StanleyMaintains91.0
CWKRaymond JamesMaintains20.0
COSTRaymond JamesMaintains410.0
CHTRRaymond JamesMaintains720.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com